InfuSystems Holdings (FRA:1TZ) EV-to-EBIT : 55.99 (As of May. 25, 2024)

View and export this data going back to 2021. Start your Free Trial

What is InfuSystems Holdings EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, InfuSystems Holdings's Enterprise Value is €172.7 Mil. InfuSystems Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was €3.1 Mil. Therefore, InfuSystems Holdings's EV-to-EBIT for today is 55.99.

The historical rank and industry rank for InfuSystems Holdings's EV-to-EBIT or its related term are showing as below:

FRA:1TZ' s EV-to-EBIT Range Over the Past 10 Years
Min: -267.37 Med: 24.07 Max: 336.85
Current: 56.22

During the past 13 years, the highest EV-to-EBIT of InfuSystems Holdings was 336.85. The lowest was -267.37. And the median was 24.07.

FRA:1TZ's EV-to-EBIT is ranked worse than
86.03% of 458 companies
in the Medical Devices & Instruments industry
Industry Median: 20.17 vs FRA:1TZ: 56.22

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. InfuSystems Holdings's Enterprise Value for the quarter that ended in Mar. 2024 was €202.0 Mil. InfuSystems Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was €3.1 Mil. InfuSystems Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 1.53%.

InfuSystems Holdings EV-to-EBIT Historical Data

The historical data trend for InfuSystems Holdings's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InfuSystems Holdings EV-to-EBIT Chart

InfuSystems Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

61.25

47.08

147.72

141.74

64.18

InfuSystems Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-EBIT	Get a 7-Day Free Trial															103.98	80.41	63.81	64.18	65.31

Competitive Comparison of InfuSystems Holdings's EV-to-EBIT

For the Medical Instruments & Supplies subindustry, InfuSystems Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

InfuSystems Holdings's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, InfuSystems Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where InfuSystems Holdings's EV-to-EBIT falls into.

InfuSystems Holdings EV-to-EBIT Calculation

InfuSystems Holdings's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	172.675	/	3.084
	=	55.99

InfuSystems Holdings's current Enterprise Value is €172.7 Mil.
InfuSystems Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €3.1 Mil.

InfuSystems Holdings (FRA:1TZ) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

InfuSystems Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 )	=	EBIT	/	Enterprise Value (Q: Mar. 2024 )
	=	3.084	/	202.0074
	=	1.53 %

InfuSystems Holdings's Enterprise Value for the quarter that ended in Mar. 2024 was €202.0 Mil.
InfuSystems Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €3.1 Mil.

InfuSystems Holdings EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of InfuSystems Holdings's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

InfuSystems Holdings (FRA:1TZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InfuSystems Holdings Inc (FRA:1TZ) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

INFU:USA

Address

3851 West Hamlin Road, Rochester Hills, MI, USA, 48309

Website

http://www.infusystem.com

InfuSystems Holdings Inc is a United States based healthcare service provider. It offers Infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers, and other sites of care from the locations in the United States and Canada. The company provides products and services to hospitals, oncology practices and chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The segments of the company are Integrated Therapy Services (ITS) and Durable Medical Equipment (DME) services, of which key revenue is derived from the ITS segment.

InfuSystems Holdings (FRA:1TZ) Headlines

No Headlines